Xilio Therapeutics logo

Xilio Therapeutics

XLO | NASDAQ
Chart Builder DCF Calculator
$7.70
-$0.37 (-4.64%)
At close: Nov 16, 2026, 4:00 PM ET
$7.70
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.64%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
48
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #326/1021 (Top 32%)

Key Statistics

Market Data

Market Cap $151.6M
1D Range
7.10 8.44
52W Range
7.10 11.30

Valuation (TTM)

PE -19.25
PB 2.22
EV/EBITDA -3.48

Valuation (NTM)

Forward PE 1.54
Forward PEG 0.48
Price Target $16.00
Loading financial charts...

Profile

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX1...

Sector Healthcare
Industry Biotechnology
Employees 76
IPO Date Oct 22, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.3
Beat +67.91%
REV
$9.98M
Beat +102.85%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.